LENSAR Inc LNSR
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-09-21 |
| Shares Out. | 12,280,000 |
| Website | lensar.com/ ↗ |
| Phone | 18885367271 |
| Employees | 150 |
| Revenue | $13.4M |
| Gross Profit | $6.4M |
| Net Income | $36.3M |
| Free Cash Flow | -$12.2M |
| Total Assets | $66.2M |
| Total Liabilities | $41.6M |
| Equity | $10.8M |
About LENSAR Inc
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
LENSAR Inc is a publicly traded company under the ticker symbol LNSR on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-07-01)